Erratum: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy (Oncotarget (2015) 6 (13671–13687) DOI: 10.18632/oncotarget.3701)

Tsung I. Hsu, Ying Jung Chen, Chia Yang Hung, Yi Chang Wang, Sin Jin Lin, Wu Chou Su, Ming Derg Lai, Sang Yong Kim, Qiang Wang, Keduo Qian, Masuo Goto, Yu Zhao, Yoshiki Kashiwada, Kuo Hsiung Lee, Wen Chang Chang, Jan Jong Hung

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

This article has been corrected: The control data used in the assembly of Figure 5 was incorrect. After reviewing all of the raw data, an updated Figure 5 was created and is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original languageEnglish
Pages (from-to)6536-6537
Number of pages2
JournalOncotarget
Volume10
Issue number60
Publication statusPublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Erratum: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy (Oncotarget (2015) 6 (13671–13687) DOI: 10.18632/oncotarget.3701)'. Together they form a unique fingerprint.

Cite this